For instance, in oral squamous cell carcinoma, downregulation of LCN2 leads to increased survival, proliferation, migration, and chemoresistance via the LKB1-AMPK-p53-Redd1-mTOR axis (17). This evidence concerns the gene LCN2 and oral cavity squamous cell carcinoma.